Enzymatic inhibition of MICA sheddase ADAM17 by lomofungin in hepatocellular carcinoma cells
Jun Arai(Showa University), Naoya Kato(The University of Tokyo)
Cited by 35
Related Papers
Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial
|Annals of Oncology|2019|333
Soluble MICA and a MICA Variation as Possible Prognostic Biomarkers for HBV-Induced Hepatocellular Carcinoma
|PLoS ONE|2012|94
A genome-wide association study of HCV-induced liver cirrhosis in the Japanese population identifies novel susceptibility loci at the MHC region
|Journal of Hepatology|2013|64
Interferon‑γ induced PD‑L1 expression and soluble PD‑L1 production in gastric cancer
|Oncology Letters|2020|51